I
IXHL
Incannex Healthcare Ltd
0.46
0.05+12.96%After Hours: 0.4618 +0.0043 +0.94%18:58 08/21 EDT
OPEN/PREV CLOSE0.3956/0.4050
TODAY RANGE0.3945-0.4930
VOL158.12M
MARKET CAP13.47M
52 WEEK RANGE0.0800-3.120
AVG VOL (3M)106.88M
% TURNOVER537.22%
TURNOVER--
P/E (TTM)-0.3741
% RANGE24.32%
EPS(TTM)-1.2229
P/E(FORWARD)-0.4794
P/B1.099
BVPS0.4162
DIVIDEND--
P/S571.88
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.95M
SHARES OUTSTANDING29.43M
NEXT EARNINGS09/26-10/04
FREE FLOAT21.74M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/08 12:32
Incannex Healthcare Reports Positive Phase 2 Trial Results
TipRanks·08/08 12:10
Incannex announces patient-reported outcomes, efficacy data for IXHL-42X
Benzinga·08/01 20:52
EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?
Benzinga·08/01 10:56
Why Apple Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
TipRanks·07/31 12:29
Incannex Healthcare Highlights Strong Cash Position and Strategy
TipRanks·07/31 12:22
Incannex has no plans, requirement to fully utilized ATM in near term
Benzinga·07/31 11:00
Why Meta Platforms Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Seeking Alpha·07/30 18:14
Incannex drops despite mid-stage trial win for lead asset in sleep apnoea
Benzinga·07/30 14:10
Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial
TipRanks·07/30 12:32
Incannex Reports Positive Phase 2 Trial Results
Same Industry
Name/Symbol
Change%
Price